 NEW YORK, March 03, 2021 GLOBE NEWSWIRE -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Immunovant, Inc. fka Health Sciences Acquisitions Corporation NASDAQ: IMVT, HSACU, HSAC, HSACW between October 2, 2019 and February 1, 2021, inclusive the Class Period. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 20, 2021. 